
Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides
<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxQSGE1c2VNNWFybGo3aU9WcjJCS3BKam54NjFVWkNVQTlHa1J1Z1EzMHY1ZWd3N3kxa0ZLazlSZ0M3UUg2ejdJVDh6c2p1MUtpMG4xcnRXTlBFb0VSaW5GemNrcjdOS1ItYkM2alhwWUJpbjdOZV9WTnRTRXVRc1d5VGxrUFdrb3ZMa2xhX3lVRFExQjFramNnc2FvTURQVWh5T3VEeGk4OUw0TmY2MURMcjd0TlRYTEFIUFF4QjhXRHVqUnZXYTVESVYySllRZE5aNlpkRUQtLVExd1NjejNkc1JieU9hWHVVOXRONXdMT0ZTeFJWM045XzUwUDA?oc=5" target="_blank">Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides</a>&nbsp;&nbsp;<font color="#6f6f6f">Cleveland Clinic Newsroom</font>

